Australia's Imricor Medical Systems soars on US FDA clearance for MRI catheter

Shares of Australia's Imricor Medical Systems IMR.AX rise as much as 26% to A$1.99, their highest level since July 21, 2021

Stock posts its biggest intraday pct gain in nearly three years

Medical device developer says the U.S. Food and Drug Administration (FDA) has granted clearance to commercially market its Vision-MR Diagnostic Catheter

Vision-MR Diagnostic Catheter enables electrophysiologists to use MRI for precise, clear visualisation of cardiac anatomy

IMR rose 12.5% in 2025